PNC Financial Services Group Inc. Has $5.57 Million Stock Holdings in The Cooper Companies, Inc. $COO

PNC Financial Services Group Inc. trimmed its position in The Cooper Companies, Inc. (NASDAQ:COO) by 4.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 78,202 shares of the medical device company’s stock after selling 3,472 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Cooper Companies were worth $5,565,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT bought a new position in shares of Cooper Companies in the 1st quarter valued at about $33,000. GKV Capital Management Co. Inc. acquired a new position in Cooper Companies in the first quarter valued at approximately $40,000. J.Safra Asset Management Corp boosted its stake in Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after acquiring an additional 340 shares during the last quarter. Assetmark Inc. boosted its stake in Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after acquiring an additional 483 shares during the last quarter. Finally, Larson Financial Group LLC grew its holdings in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company’s stock worth $61,000 after acquiring an additional 664 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Up 0.5%

Shares of Cooper Companies stock opened at $72.13 on Monday. The company has a market capitalization of $14.34 billion, a P/E ratio of 35.53, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The business has a 50-day moving average of $69.70 and a two-hundred day moving average of $72.23. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $106.63.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The business had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the previous year, the firm earned $0.96 EPS. Cooper Companies’s quarterly revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies declared that its board has authorized a stock repurchase program on Wednesday, September 17th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Barclays assumed coverage on Cooper Companies in a research note on Monday, October 13th. They issued an “overweight” rating and a $85.00 price target on the stock. Needham & Company LLC reissued a “buy” rating and issued a $94.00 target price on shares of Cooper Companies in a research note on Thursday, August 28th. Weiss Ratings restated a “sell (d+)” rating on shares of Cooper Companies in a report on Thursday. BNP Paribas Exane raised Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price target for the company in a research note on Tuesday, July 22nd. Finally, Piper Sandler cut their price target on shares of Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $84.77.

Insider Buying and Selling

In related news, EVP Brian G. Andrews acquired 1,525 shares of the stock in a transaction dated Tuesday, September 2nd. The stock was bought at an average price of $65.68 per share, with a total value of $100,162.00. Following the completion of the transaction, the executive vice president directly owned 22,191 shares of the company’s stock, valued at approximately $1,457,504.88. The trade was a 7.38% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Albert G. White III acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, September 5th. The stock was bought at an average cost of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the transaction, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. This represents a 4.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders have acquired 17,975 shares of company stock valued at $1,216,346. 1.98% of the stock is owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.